Switching HIV ART With Resistance
Switching ART in a Virologically Suppressed Person With Suspected Underlying Resistance

Released: October 20, 2022

Expiration: October 19, 2023

Timothy Wilkin
Timothy Wilkin, MD, MPH

Activity

Progress
1
Course Completed
In this episode, Timothy J. Wilkin, MD, MPH, provides a case-based overview of switching antiretroviral therapy in a patient with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations. Key findings from 2 relevant studies—the SWITCHMRK trial and Study 380-4030—are reviewed. The case discussion also highlights several other challenges that can be encountered in the switch setting, including incomplete immune recovery, comorbidities, and gastrointestinal intolerability of some antiretroviral drugs.